In the current study, dynamic enhanced MRI radiomics was demonstrated to be capable to predict therapeutic response in hepatocellular carcinoma treated with transcatheter arterial chemoembolization, which will provide more prognostic information and facilitate clinical management.
This abstract and the presentation materials are available to members only; a login is required.